These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 30939217)

  • 1. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal hematopoiesis and hematological malignancy.
    Dunn WG; McLoughlin MA; Vassiliou GS
    J Clin Invest; 2024 Oct; 134(19):. PubMed ID: 39352393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 5. Preleukemia. Cytogenetic clues in some confusing disorders.
    Nowell PC
    Am J Pathol; 1977 Nov; 89(2):459-76. PubMed ID: 335894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preleukemia: one name, many meanings.
    Koeffler HP; Leong G
    Leukemia; 2017 Mar; 31(3):534-542. PubMed ID: 27899806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T
    Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
    Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ
    Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].
    Kreipe HH
    Pathologe; 2011 Nov; 32 Suppl 2():271-6. PubMed ID: 22033685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
    Ueda K; Ikeda K
    Fukushima J Med Sci; 2024 Jan; 70(1):11-24. PubMed ID: 37952978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant progression of preleukemic disorders.
    Hall T; Gurbuxani S; Crispino JD
    Blood; 2024 May; 143(22):2245-2255. PubMed ID: 38498034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging patterns in clonal haematopoiesis.
    Capo-Chichi JM; Michaels P; Tremblay-Le May R; Abelson S; Hasserjian RP; Xia D
    J Clin Pathol; 2019 Jul; 72(7):453-459. PubMed ID: 31164443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders.
    Hayashi Y; Harada H
    Cancer Sci; 2023 Jul; 114(7):2722-2728. PubMed ID: 37026511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.
    Corces-Zimmerman MR; Hong WJ; Weissman IL; Medeiros BC; Majeti R
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2548-53. PubMed ID: 24550281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.